Which of the following is true regarding the combination tablet containing telmisartan, amlodipine, and indapamide? A. It is the only FDA-approved three-in-one antihypertensive combination tablet B. Additional safety concerns exist with the combination tablet that were not seen with each individual component C. It combines an ACE inhibitor, a calcium channel blocker, and a thiazide-like diuretic D. Patients can expect to see almost all of the efficacy of this combination within the first 2 weeks of a dose change
[Verified Answer]: Which of the following is true regarding…
Need help with your Cardiovascular Pharmacology case study or NCLEX preparation? Connect with a verified Nursing expert now.